+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Abdominal Aneurysms - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aneurysms - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Norovirus Enteritis-Pipeline - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Norovirus Enteritis-Pipeline - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Diarrheal Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Diarrheal Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2025 - Product Thumbnail Image

Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gastro Intestinal Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Gastro Intestinal Bleeding - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Intestinal Obstruction - Pipeline Insight, 2025 - Product Thumbnail Image

Intestinal Obstruction - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Constipation- Pipeline Insight, 2025 - Product Thumbnail Image

Constipation- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Anal Fistula- Pipeline Insight, 2025 - Product Thumbnail Image

Anal Fistula- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Abdominal Aortic Aneurysm - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aortic Aneurysm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Erosive Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Diverticulitis - Pipeline Insight, 2025 - Product Thumbnail Image

Diverticulitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more